Adenosine receptor agonists differentially affect the anticonvulsant action of carbamazepine and valproate against maximal electroshock test-induced seizures in mice

Abbracchio M.P., Brambilla R., Ceruti S., Kim H.O., von Lubitz D.K., Jacobson K.A. et al.:G protein-dependent activation of phospholipase C by adenosine A₃ receptors in rat brain. Mol. Pharmacol., 1995; 48: 1038–1045.Search in Google Scholar

Assi A.A.:N⁶-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice. J. Pharm. Sci., 2001, 4: 42–51.Search in Google Scholar

Booker S.A., Pires N., Cobb S., Soares-da-Silva P., Vida I.:Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors. Neuropharmacology, 2015, 93: 103–115.10.1016/j.neuropharm.2015.01.019Search in Google Scholar

Borowicz K.K., Kamiński R., Gasior M., Kleinrok Z., Czuczwar S.J.:Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur. Neuropsychopharmacol., 1999, 9: 185–190.10.1016/S0924-977X(98)00022-4Search in Google Scholar

Borowicz K.K., Kleinrok Z., Czuczwar S.J.:N⁶-2-(4 -aminophenyl) ethyl-adenosine enhances the anticonvulsive activity of antiepileptic drugs. Eur. J. Pharmacol., 1997, 327: 125–133.10.1016/S0014-2999(97)89651-3Search in Google Scholar

Borowicz K.K., Kleinrok Z., Czuczwar S.J.:N(6)-2-(4-aminophenyl) ethyl-adenosine enhances the anticonvulsive action of conventional antiepileptic drugs in the kindling model of epilepsy in rats. Eur. Neuropsychopharmacol., 2000, 10: 237–243.10.1016/S0924-977X(00)00081-XSearch in Google Scholar

Borowicz K.K., Łuszczki J., Czuczwar S.J:. 2-Chloroadenosine, a preferential agonist of adenosine A₁ receptors, enhances the anticonvulsant activity of carbamazepine and clonazepam in mice. Eur. Neuropsychopharmacol., 2002, 12: 173–179.10.1016/S0924-977X(02)00009-3Search in Google Scholar

Bynoe M.S., Viret C., Yan A., Kim D.G.:Adenosine receptor signaling: a key to opening the blood-brain door. Fluids Barriers CNS, 2015, 12: 20. doi: 10.1186/s12987-015-0017-7.10.1186/s12987-015-0017-7Search in Google Scholar

Cieślak M., Wojtczak A,. Komoszyński M.:Role of the purinergic signaling in epilepsy. Pharmacol Rep., 2017, 69: 130–138.10.1016/j.pharep.2016.09.018Search in Google Scholar

Czapiński P., Błaszczyk B., Czuczwar S.J.:Mechanisms of action of antiepileptic drugs. Curr. Top. Med. Chem., 2005, 5: 3–14.10.2174/1568026053386962Search in Google Scholar

Daly J.W., Butts-Lamb P., Padgett W.:Subclasses of adenosine receptors in the central nervous system: Interactions with caffeine and related methylxanthines. Cell. Mol. Nerobiol., 1983, 3: 69–80.10.1007/BF00734999Search in Google Scholar

Dragunow M.:Endogenous anticonvulsant substances. Neurosci. Biobehav. Rev., 1986; 10: 229–244.10.1016/0149-7634(86)90010-2Search in Google Scholar

Jasiński M., Chrościńska-Krawczyk M., Kaczmarczyk K., Czuczwar S.J.:Various adenosine receptor agonists differentially affect the anticonvulsant action of phenobarbital and phenytoin against maximal electroshock-induced seizures in mice. Epileptologia, 2011, 19: 5–15.Search in Google Scholar

Lampe H., Bigalke H.:Carbamazepine blocks NMDAactvated currents in cultured spinal cord neurons. Neuroreport, 1990, 1: 26–28.10.1097/00001756-199009000-00008Search in Google Scholar

Litchfield, J.T., Wilcoxon, F.:A simplified method of evaluating dose–effect experiments. J. Pharmacol. Exp. Ther., 1949, 96: 99–113.Search in Google Scholar

Löscher W., Schmidt D.:Which animal models should be used in the search for new antiepileptic drugs? A proposal based on the experimental and clinical considerations. Epilepsy Res., 1988, 2: 145–181.10.1016/0920-1211(88)90054-XSearch in Google Scholar

Löscher W.:New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol., 1998, 342: 1–13.10.1016/S0014-2999(97)01514-8Search in Google Scholar

Łuszczki J.J., Czuczwar S.J.:How significant is the difference between drug doses influencing the threshold for electroconvulsions? Pharmacol. Rep., 2005, 57: 782–786.Search in Google Scholar

Łuszczki J.J., Kozicka M., Świąder M.J., Czuczwar S.J.:2-Chlo-ro-N⁶-cyclopentyladenosine enhances the anticonvulsant action of carbamazepine in the mouse maximal electroshock-induced seizure model. Pharmacol. Rep., 2005, 57: 787–894.Search in Google Scholar

Macdonald R.L.:Carbamazepine. Mechanisms of action. In: R. H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca (eds.), Antiepileptic Drugs, 5^th edn. Lippincott Williams & Wilkins, Philadelphia, 2002, 227–235.Search in Google Scholar

Malhotra J., Gupta Y.K.:Effect of sdenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br. J. Pharmacol., 1997, 120: 282–288.10.1038/sj.bjp.0700869Search in Google Scholar

Marangos P.J., Post R.M., Patel J., Zander K., Parma A., Weiss S. :Specific and potent interactions of carbamazepine with brain adenosine receptors. Eur. J. Pharmacol., 1983, 93: 175–182.10.1016/0014-2999(83)90135-8Search in Google Scholar

Miziak B., Chrościńska-Krawczyk M., Błaszczyk B., Radzik I., Czuczwar S.J.:Novel approaches to anticonvulsant drug discovery. Expert Opin. Drug Discov., 2013, 8: 1415–1427.10.1517/17460441.2013.837047Search in Google Scholar

Ralevic V., Burnstock G.:Receptors for purines and pyrimidines. Pharmacol. Rev., 1998, 50: 415–492.Search in Google Scholar

Schwartzkroin P.A.:Basic Mechanism of epileptogenesis. In: E. Wyllie (ed.), The Treatment of epilepsy: Principles and practice. Lea & Febiger, Philadelphia, 1993, 83–99.Search in Google Scholar

Sebastião A.M., Ribeiro J.A.:Adenosine A₂ receptor-mediated excitatory actions on the nervous system. Prog. Neurobiol., 1996, 48: 167–189.10.1016/0301-0082(95)00035-6Search in Google Scholar

Shorvon S.D.:The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia, 1996, 37 (Suppl. 2): S1–S3.10.1111/j.1528-1157.1996.tb06027.x8641240Search in Google Scholar

Skerritt J.H., Davies L.P., Johnston G.A.:Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies. Epilepsia, 1983, 24: 634–642.10.1111/j.1528-1157.1983.tb03429.x6311525Search in Google Scholar

Sun Z., Zhong X.L., Zong Y., Wu Z.C., Zhang Q., Yu J.T. et al.:Activation of adenosine receptor potentiates the anticonvulsant effect of phenytoin against amygdala kindled seizures. CNS Neurol. Disord. Drug Targets, 2015, 14: 378–385.10.2174/187152731366614080615431423844683Search in Google Scholar

Świąder M.J., Kotowski J., Łuszczki J.J.:Modulation of adenosinergic system and its application for the treatment of epilepsy. Pharmacol. Rep., 2014, 66: 335–342.10.1016/j.pharep.2013.10.005Search in Google Scholar

Van Calker D., Muller M., Hamprecht B.:Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells. Nature, 1978, 276: 839–841.10.1038/276839a0Search in Google Scholar

Van Calker D., Steber R., Klotz K.N., Greil W.:Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur. J. Pharmacol., 1991, 206, 285–290.10.1016/0922-4106(91)90111-TSearch in Google Scholar

Young D., Dragunow M.:Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience, 1994, 58: 245–261.10.1016/0306-4522(94)90032-9Search in Google Scholar

Younus I., Reddy D.S.:A resurging boom in new drugs for epilepsy and brain disorders. Expert Rev. Clin. Pharmacol., 2017 – in press. doi: 10.1080/17512433.2018.1386553.10.1080/17512433.2018.138655328956955Search in Google Scholar

Zhang G., Franklin P.H., Murray T.F.:Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther., 1993, 264: 1415–1424.Search in Google Scholar

Zhou Q.Y., Li C., Olah M.E., Johnson R.A., Stiles G.L., Civelli O.:Molecular cloning and characterization of an adenosine receptor: the A₃ adenosine receptor. Proc. Natl. Acad. Sci. USA, 1992, 89: 7432–7436.10.1073/pnas.89.16.7432497241323836Search in Google Scholar